Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 5/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28723259 | 0.92 | TYR (0.43) | TYRESR1ESR2MEN1TP53 | |
| SCHEMBL4596678 | 0.84 | TYR (0.50) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL29492305 | 0.83 | TYR (0.48) | TYRESR1ESR2 | |
| SCHEMBL21830477 | 0.83 | TYR (0.48) | TYRESR1ESR2 | |
| SCHEMBL71452 | 0.82 | TYR (0.49) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL29131797 | 0.82 | TYR (0.40) | TYRESR1ESR2MEN1TP53 | |
| SCHEMBL7557590 | 0.81 | TYR (0.43) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL10012344 | 0.81 | TYR (0.43) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL22068259 | 0.80 | TYR (0.47) | TYRESR1MEN1TP53CYP3A4 | |
| SCHEMBL19007298 | 0.79 | TYR (0.42) | TYRESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |